In order to inform the European Commission's formal Impact Assessment for a revision to the Tobacco Products Directive, this study provides an overview of evidence for tobacco product regulation and an analysis of health and economic implications.
In the United States, chronic obstructive pulmonary disease (COPD) affects more than 5% of the adult population and is the 4th leading cause of death and the 12th leading cause of morbidity. This guideline presents the available evidence on the diagnosis and management of COPD.
In caring for patients with severe COPD, consideration should be given to implementing palliative treatments more aggressively, even while remaining open to provision of life-sustaining interventions.
Describes the events surrounding the decision by the National Heart and Lung Institute (NHLI) to issue a request for proposal (RFP) to conduct a multicenter randomized clinical trial comparing the efficacy of intermittent positive pressure breathing (IPPB) with compressor nebulizer therapy in treating patients with chronic obstructive pulmonary disease (COPD).